Management of Acute and Recurrent Pericarditis: JACC State-of-the-Art Review.
暂无分享,去创建一个
J. Grizzard | A. Abbate | F. Montecucco | A. Brucato | M. Imazio | D. Berrocal | A. Mauro | A. Bonaventura | G. Wohlford | A. Vecchié | J. Chiabrando | J. Jordan
[1] C. Jellis,et al. Imaging-Guided Therapies for Pericardial Diseases. , 2019, JACC. Cardiovascular imaging.
[2] J. Bogaert,et al. Usefulness of Cardiac Magnetic Resonance for Recurrent Pericarditis. , 2019, The American journal of cardiology.
[3] A. Sambola,et al. Colchicina administrada en el primer episodio de pericarditis aguda idiopática: estudio multicéntrico abierto y aleatorizado , 2019, Revista Española de Cardiología.
[4] M. Senni,et al. Constrictive pericarditis: a common physiopathology for different macroscopic anatomies. , 2019, Journal of cardiovascular medicine.
[5] F. Ecarnot,et al. Pericardiectomy for constrictive pericarditis: a risk factor analysis for early and late failure , 2019, Heart and Vessels.
[6] P. Cacoub,et al. Corticosteroids and immunosuppressive agents for idiopathic recurrent pericarditis. , 2019, Autoimmunity reviews.
[7] Y. Shoenfeld,et al. Anakinra in idiopathic recurrent pericarditis refractory to immunosuppressive therapy; a preliminary experience in seven patients. , 2019, Autoimmunity reviews.
[8] R. Herbst,et al. Immune Checkpoint Inhibitor-Associated Pericarditis. , 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[9] A. Klein,et al. Multimodality Imaging for the Assessment of Pericardial Diseases , 2019, Current Cardiology Reports.
[10] A. Klein,et al. Pericardial diseases in patients with hypothyroidism , 2019, Heart.
[11] R. Manka,et al. Non-steroidal anti-inflammatory drug use in acute myopericarditis: 12-month clinical follow-up , 2019, Open Heart.
[12] D. Phelan,et al. Exercise Is Good for the Heart But Not for the Inflamed Pericardium? , 2019, JACC. Cardiovascular imaging.
[13] A. Klein,et al. RILONACEPT IN RECURRENT PERICARDITIS: FIRST EFFICACY AND SAFETY DATA FROM AN ONGOING PHASE 2 PILOT CLINICAL TRIAL , 2019, Journal of the American College of Cardiology.
[14] F. Montecucco,et al. Inflammation and pericarditis: Are neutrophils actors behind the scenes? , 2018, Journal of cellular physiology.
[15] M. Ntsekhe,et al. Epidemiology of pericardial diseases in Africa: a systematic scoping review , 2018, Heart.
[16] R. Kornowski,et al. Prodromal symptoms predict myocardial involvement in patients with acute idiopathic pericarditis. , 2018, International journal of cardiology.
[17] A. Garin,et al. Metropolitan W135 meningococcal compressive pericarditis treated with intrapericardial fibrinolysis , 2018, BMJ Case Reports.
[18] M. Böhm,et al. The first post-cardiac injury syndrome reported following transcatheter aortic valve implantation: a case report , 2018, European Heart Journal: Case Reports.
[19] G. Bertsias,et al. Canakinumab for recurrent rheumatic disease associated-pericarditis: a case series with long-term follow-up. , 2018, Rheumatology.
[20] Y. Adler,et al. Recurrent pericarditis: still idiopathic? The pros and cons of a well-honoured term , 2018, Internal and Emergency Medicine.
[21] Arjun K. Ghosh,et al. Pericardial Disease in Cancer Patients , 2018, Current Treatment Options in Cardiovascular Medicine.
[22] A. Abbate,et al. The NLRP3 inflammasome in acute myocardial infarction , 2018, Nature Reviews Cardiology.
[23] Sung‐A Chang. Tuberculous and Infectious Pericarditis. , 2017, Cardiology clinics.
[24] Amjad M Ahmed,et al. Multimodality Imaging of Pericardial Diseases , 2017, Current Treatment Options in Cardiovascular Medicine.
[25] R. Kornowski,et al. Seasonal patterns of acute and recurrent idiopathic pericarditis , 2017, Clinical cardiology.
[26] P. T. Ureta,et al. Idiopathic relapsing acute pericarditis: Report of one case with favorable response to anakinra. , 2017, Medicina clinica.
[27] C. Wiysonge,et al. Interventions for treating tuberculous pericarditis , 2017, The Cochrane database of systematic reviews.
[28] F. Gaita,et al. Acute and Recurrent Pericarditis: Still Idiopathic? , 2017, Journal of the American College of Cardiology.
[29] B. Tamarappoo,et al. Quantitative Pericardial Delayed Hyperenhancement Informs Clinical Course in Recurrent Pericarditis. , 2017, JACC. Cardiovascular imaging.
[30] A. Brucato,et al. Is colchicine really harmful in viral myocarditis? , 2017, International journal of cardiology.
[31] S. Hyun,et al. [18F]Fluorodeoxyglucose PET/CT Predicts Response to Steroid Therapy in Constrictive Pericarditis. , 2017, Journal of the American College of Cardiology.
[32] P. Herbst,et al. Redefining Effusive-Constrictive Pericarditis with Echocardiography , 2016, Journal of cardiovascular ultrasound.
[33] Arnav Kumar,et al. Complicated Pericarditis: Understanding Risk Factors and Pathophysiology to Inform Imaging and Treatment. , 2016, Journal of the American College of Cardiology.
[34] M. Sormani,et al. Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence: The AIRTRIP Randomized Clinical Trial. , 2016, JAMA.
[35] S. Heymans,et al. Colchicine aggravates coxsackievirus B3 infection in mice. , 2016, International journal of cardiology.
[36] H. Schaff,et al. A 20-year experience with isolated pericardiectomy: Analysis of indications and outcomes. , 2016, The Journal of thoracic and cardiovascular surgery.
[37] M. Link,et al. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Associat , 2015, Circulation.
[38] V. Kraus,et al. Colchicine--Update on mechanisms of action and therapeutic uses. , 2015, Seminars in arthritis and rheumatism.
[39] N. Al-Attar,et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases , 2015, European heart journal.
[40] F. Gaita,et al. Evaluation and Treatment of Pericarditis: A Systematic Review. , 2015, JAMA.
[41] S. Bressieux-Degueldre,et al. A case of corticosteroid-dependent recurrent pericarditis with different response to two IL-1 blocking agents , 2015, Pediatric Rheumatology.
[42] M. Carrier,et al. Pericardiectomy for Constrictive Pericarditis: 20 Years of Experience at the Montreal Heart Institute. , 2015, The Annals of thoracic surgery.
[43] D. Raoult,et al. Etiology of Pericarditis in a Prospective Cohort of 1162 Cases. , 2015, The American journal of medicine.
[44] M. Abraham,et al. Propionibacterium acnes: A Treatable Cause of Constrictive Pericarditis , 2015, Case reports in medicine.
[45] P. Cremer,et al. Multimodality Imaging of Pericardial Disease , 2015, Current Cardiology Reports.
[46] B. Griffin,et al. Usefulness of cardiac magnetic resonance-guided management in patients with recurrent pericarditis. , 2015, The American journal of cardiology.
[47] J. Coons,et al. Pharmacotherapy Update of Acute Idiopathic Pericarditis , 2015, Pharmacotherapy.
[48] S. Achenbach,et al. European Association of Cardiovascular Imaging (EACVI) position paper: Multimodality imaging in pericardial disease. , 2014, European heart journal cardiovascular Imaging.
[49] D. H. Spodick,et al. Colchicine for pericarditis. , 2014, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[50] P. Andersen,et al. Relation of nonsteroidal anti-inflammatory drugs to serious bleeding and thromboembolism risk in patients with atrial fibrillation receiving antithrombotic therapy: a nationwide cohort study. , 2014, Annals of internal medicine.
[51] Masafumi Takahashi,et al. Letter by Takahashi regarding article "targeting interleukin-1 in heart disease". , 2014, Circulation.
[52] Y. Adler,et al. Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial , 2014, The Lancet.
[53] H. Wiste,et al. Echocardiographic Diagnosis of Constrictive Pericarditis: Mayo Clinic Criteria , 2014, Circulation. Cardiovascular imaging.
[54] K. Sliwa,et al. HIV and the heart: the impact of antiretroviral therapy: a global perspective. , 2013, European heart journal.
[55] J. Tardif,et al. Management of pericarditis and myocarditis: could heart-rate-reducing drugs hold a promise? , 2013, Archives of cardiovascular diseases.
[56] M. Karck,et al. Constrictive pericarditis: risks, aetiologies and outcomes after total pericardiectomy: 24 years of experience. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[57] E. Fabris,et al. Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis. , 2013, The American journal of cardiology.
[58] Y. Adler,et al. A randomized trial of colchicine for acute pericarditis. , 2013, The New England journal of medicine.
[59] B. Hoit,et al. Post-cardiac injury syndromes. An emerging cause of pericardial diseases. , 2013, International journal of cardiology.
[60] Richard D. White,et al. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. , 2013, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[61] I. Touitou,et al. The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry , 2013, Annals of the rheumatic diseases.
[62] G. Ligabue,et al. Good Prognosis for Pericarditis With and Without Myocardial Involvement: Results From a Multicenter, Prospective Cohort Study , 2013, Circulation.
[63] R. Nishimura,et al. Mechanism of septal bounce in constrictive pericarditis: a simultaneous cardiac catheterisation and echocardiographic study , 2013, Heart.
[64] Y. Jang,et al. The incidence and clinical outcome of constrictive physiology after coronary artery bypass graft surgery. , 2013, Journal of the American College of Cardiology.
[65] S. Flamm,et al. Biventricular Mechanics in Constrictive Pericarditis Comparison With Restrictive Cardiomyopathy and Impact of Pericardiectomy , 2013, Circulation. Cardiovascular imaging.
[66] J. Oh,et al. Echocardiography in pericardial diseases: new developments , 2013, Heart Failure Reviews.
[67] J. Oh,et al. Effusive-constrictive pericarditis , 2013, Heart Failure Reviews.
[68] A. Ristic,et al. Pericardioscopy and epi- and pericardial biopsy—a new window to the heart improving etiological diagnoses and permitting targeted intrapericardial therapy , 2013, Heart Failure Reviews.
[69] H. Schaff,et al. Pericardiectomy vs medical management in patients with relapsing pericarditis. , 2012, Mayo Clinic proceedings.
[70] W. Edwards,et al. MR imaging findings in 76 consecutive surgically proven cases of pericardial disease with CT and pathologic correlation , 2012, The International Journal of Cardiovascular Imaging.
[71] H. Schaff,et al. Completion pericardiectomy for recurrent constrictive pericarditis: importance of timing of recurrence on late clinical outcome of operation. , 2012, The Annals of thoracic surgery.
[72] Y. Adler,et al. Efficacy and safety of colchicine for pericarditis prevention. Systematic review and meta-analysis , 2012, Heart.
[73] Jeroen J. Bax,et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). , 2011, European heart journal.
[74] D. Choi,et al. Effects of simvastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, after oral and intravenous administration in rats: possible role of P-glycoprotein and CYP3A4 inhibition by simvastatin , 2011, Pharmacological reports : PR.
[75] S. Flamm,et al. Pericardial delayed hyperenhancement with CMR imaging in patients with constrictive pericarditis undergoing surgical pericardiectomy: a case series with histopathological correlation. , 2011, JACC. Cardiovascular imaging.
[76] Matthew W. Martinez,et al. Cardiac Magnetic Resonance Imaging Pericardial Late Gadolinium Enhancement and Elevated Inflammatory Markers Can Predict the Reversibility of Constrictive Pericarditis After Antiinflammatory Medical Therapy: A Pilot Study , 2011, Circulation.
[77] Y. Adler,et al. Contemporary features, risk factors, and prognosis of the post-pericardiotomy syndrome. , 2011, American Journal of Cardiology.
[78] Y. Adler,et al. Colchicine for Recurrent Pericarditis (CORP) , 2011, Annals of Internal Medicine.
[79] D. Adam,et al. Speckle Tracking Imaging in Acute Inflammatory Pericardial Diseases , 2011, Echocardiography.
[80] F. Cinetto,et al. Azathioprine in isolated recurrent pericarditis: a single centre experience. , 2011, International journal of cardiology.
[81] A. Brucato,et al. Prevalence of C-Reactive Protein Elevation and Time Course of Normalization in Acute Pericarditis: Implications for the Diagnosis, Therapy, and Prognosis of Pericarditis , 2011, Circulation.
[82] S. Yusuf,et al. Radiation-Induced Heart Disease: A Clinical Update , 2011, Cardiology research and practice.
[83] E. Belley‐Cote,et al. Acute and recurring pericarditis: More colchicine, less corticosteroids. , 2010, World journal of cardiology.
[84] Y. Adler,et al. Triage and management of pericardial effusion , 2010, Journal of cardiovascular medicine.
[85] G. Biondi-Zoccai,et al. International collaborative systematic review of controlled clinical trials on pharmacologic treatments for acute pericarditis and its recurrences. , 2010, American heart journal.
[86] M. Desai,et al. The Role of Multimodality Imaging in the Management of Pericardial Disease , 2010, Circulation. Cardiovascular imaging.
[87] J. Oh,et al. Infectious pericarditis: an experience spanning a decade , 2009, Acta cardiologica.
[88] Y. Adler,et al. Aetiological diagnosis in acute and recurrent pericarditis: when and how , 2009, Journal of cardiovascular medicine.
[89] G. Brambilla,et al. Corticosteroids for Recurrent Pericarditis: High Versus Low Doses: A Nonrandomized Observation , 2008, Circulation.
[90] B. Mayosi. Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa , 2007, Heart.
[91] R. Shabetai,et al. Pathogenesis, management, and prevention of recurrent pericarditis , 2007, Journal of cardiovascular medicine.
[92] L. Coda,et al. Indicators of Poor Prognosis of Acute Pericarditis , 2007, Circulation.
[93] J. Seward,et al. Apex-to-base dispersion in regional timing of left ventricular shortening and lengthening. , 2006, Journal of the American College of Cardiology.
[94] B. Mayosi,et al. Tuberculous Pericarditis , 2005, Circulation.
[95] M. Imazio,et al. Colchicine in Addition to Conventional Therapy for Acute Pericarditis: Results of the COlchicine for acute PEricarditis (COPE) Trial , 2005, Circulation.
[96] M. Imazio,et al. Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. , 2005, Archives of internal medicine.
[97] Richard A. Lange,et al. Clinical practice. Acute pericarditis. , 2004, The New England journal of medicine.
[98] D. Girling,et al. Management of tuberculous constrictive pericarditis and tuberculous pericardial effusion in Transkei: results at 10 years follow-up. , 2004, QJM : monthly journal of the Association of Physicians.
[99] M. Lauer,et al. Constrictive pericarditis: etiology and cause-specific survival after pericardiectomy. , 2004, Journal of the American College of Cardiology.
[100] M. Imazio,et al. Day-hospital treatment of acute pericarditis: a management program for outpatient therapy. , 2004, Journal of the American College of Cardiology.
[101] G. Permanyer-Miralda. Acute pericardial disease: approach to the aetiologic diagnosis , 2004, Heart.
[102] D. Faxon,et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echoca , 2003, Journal of the American College of Cardiology.
[103] D. H. Spodick,et al. Acute cardiac tamponade. , 2003, The New England journal of medicine.
[104] J. Soler‐Soler,et al. Clinical clues to the causes of large pericardial effusions. , 2000, The American journal of medicine.
[105] S. Hernández-Díaz,et al. Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. , 2000, Archives of internal medicine.
[106] P. Touboul,et al. Serum cardiac troponin I and ST-segment elevation in patients with acute pericarditis. , 2000, European heart journal.
[107] J. Seward,et al. Calcific Constrictive Pericarditis: Is It Still with Us? , 2000, Annals of Internal Medicine.
[108] A. Evangelista,et al. Correlation between clinical and Doppler echocardiographic findings in patients with moderate and large pericardial effusion: implications for the diagnosis of cardiac tamponade. , 1999, American heart journal.
[109] J. Seward,et al. Constrictive pericarditis in the modern era: evolving clinical spectrum and impact on outcome after pericardiectomy. , 1999, Circulation.
[110] A. Whelton. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. , 1999, The American journal of medicine.
[111] B. Pedersen,et al. Exercise and Immune Function , 1999, Sports medicine.
[112] J. Soler‐Soler,et al. Should pericardial drainage be performed routinely in patients who have a large pericardial effusion without tamponade? , 1998, The American journal of medicine.
[113] W. Edwards,et al. Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases. , 1996, Human pathology.
[114] R. Swanton,et al. How do the clinical findings in patients with pericardial effusions influence the success of aspiration? , 1995, British heart journal.
[115] B. Hoit,et al. The Paradoxical Pulse in Tamponade: Mechanisms and Echocardiography Correlates , 1994, Echocardiography.
[116] J. Soler‐Soler,et al. Purulent pericarditis: review of a 20-year experience in a general hospital. , 1993, Journal of the American College of Cardiology.
[117] R. Siegel,et al. Rapid resolution of symptomatic acute pericarditis with ketorolac tromethamine: a parenteral nonsteroidal antiinflammatory agent. , 1993, American heart journal.
[118] D. Felson,et al. A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. , 1993, Archives of internal medicine.
[119] S. Rezkalla,et al. Enhancement of coxsackievirus B4 virulence by indomethacin. , 1990, The Journal of laboratory and clinical medicine.
[120] E. W. Hancock,et al. The etiologic spectrum of constrictive pericarditis. , 1987, American heart journal.
[121] J. A. Robinson,et al. A nonsteroid anti-inflammatory drug exacerbates Coxsackie B3 murine myocarditis. , 1985, Journal of the American College of Cardiology.
[122] J. Doppman,et al. Constrictive pericardial disease: prognostic significance of a nonvisualized left ventricular wall. , 1985, Radiology.
[123] R. Rubin,et al. Clinical, microbiologic and therapeutic aspects of purulent pericarditis. , 1975, The American journal of medicine.
[124] D. Spodick. Electrocardiogram in acute pericarditis. Distributions of morphologic and axial changes by stages. , 1974, The American journal of cardiology.
[125] C. Wilson,et al. The induction of gross myocardial lesions by a Coxsackie (pleurodynia) virus and cortisone. , 1956, The Journal of clinical investigation.
[126] C. Asher,et al. Pericarditis , 1830, The Medico-chirurgical review.
[127] L. Buckley,et al. Interleukin-1 blockade for the treatment of pericarditis , 2018, European heart journal. Cardiovascular pharmacotherapy.
[128] S. Seth,et al. NT pro B type natriuretic peptide levels in constrictive pericarditis and restrictive cardiomyopathy. , 2015, Indian heart journal.
[129] A. Clark,et al. Fluid Management in Patients with Chronic Heart Failure , 2015 .
[130] M. Link,et al. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Associat , 2015, Journal of the American College of Cardiology.
[131] P. Rautava,et al. [Clinical profile and influences on outcomes in patients hospitalized for acute pericarditis]. , 2014, Duodecim; laaketieteellinen aikakauskirja.
[132] J. Stockman. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort , 2011 .
[133] D. Spodick,et al. Contemporary Reviews in Cardiovascular Medicine Controversial Issues in the Management of Pericardial Diseases , 2010 .
[134] J. Seward,et al. Disparate patterns of left ventricular mechanics differentiate constrictive pericarditis from restrictive cardiomyopathy. , 2008, JACC. Cardiovascular imaging.
[135] M. Yacoub,et al. [Guidelines on the diagnosis and management of pericardial diseases. Executive summary]. , 2004, Revista espanola de cardiologia.
[136] Pamela S Douglas,et al. Acc/aha/ase 2003 Guideline Update for the Clinical Application of Echocardiography: Summary Article a Report of the American College of Cardiology/american Heart Association Task Force on Practice Guidelines (acc/aha/ase Committee to Update the 1997 Guidelines for the Clinical Application of Echocar , 2003 .
[137] D. Spodick,et al. The normal and diseased pericardium: current concepts of pericardial physiology, diagnosis and treatment. , 1983, Journal of the American College of Cardiology.
[138] See Clinical Perspective , 2022 .